您的位置: 首页 > 农业专利 > 详情页

Modulowanie ekspresji czynnika XI
专利权人:
Inc.;Ionis Pharmaceuticals
发明人:
FREIER, SUSAN M.,MONIA, BRETT P.,ZHANG, HONG,ZHAO, CHENGUANG,CROSBY, JEFFREY R.,SIWKOWSKI, ANDREW M.
申请号:
PL09821293
公开号:
PL2379084T3
申请日:
2009.10.15
申请国别(地区):
PL
年份:
2018
代理人:
摘要:
Disclosed herein are antisense compounds and methods for decreasing Factor 11 and treating or preventing thromboembolic complications in an individual in need thereof. Examples of disease conditions that can be ameliorated with the administration of antisense compounds targeted to Factor 11 include thrombosis, embolism, and thromboembolism, such as, deep vein thrombosis, pulmonary embolism, myocardial infarction, and stroke. Antisense compounds targeting Factor 11 can also be used as a prophylactic treatment to prevent individuals at risk for thrombosis and embolism.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充